FDA Approves Gilead's Biannual Injection for HIV Prevention in the US
The FDA has approved Gilead's groundbreaking twice-yearly injection to prevent HIV, offering a powerful new tool in the fight against the virus with over 99.9% efficacy demonstrated in clinical trials.
On June 18, 2025, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences' innovative twice-yearly injection designed to prevent HIV transmission. This landmark approval marks a significant advancement in HIV prevention strategies, providing a long-lasting alternative to daily oral medications. The injectable treatment, marketed as Yeztugo and containing the drug lenacapavir, has demonstrated in clinical trials the ability to reduce the risk of HIV infection by over 99.9% in adults and adolescents, effectively functioning like a powerful vaccine.
Pre-exposure prophylaxis (PrEP) medications have been available for over ten years, mainly in pill form requiring daily intake. However, adherence challenges have limited their impact on reducing global infection rates. This new injectable offers a promising solution by minimizing the need for frequent dosing, which could enhance compliance and broadening prevention efforts.
Despite the excitement surrounding this development, concerns about accessibility remain. Although Gilead has not announced official pricing, analysts estimate the US launch price could reach up to $25,000 annually. HIV activists are calling for the price to be significantly lowered—around $25 per year—to ensure widespread access and help end the HIV pandemic.
The approval comes at a time when U.S. funding for HIV treatment and prevention programs has been cut by the current administration, both domestically and internationally, raising questions about equitable access to this promising new tool. Still, health experts believe that this innovation could transform HIV prevention, reducing new infections and saving lives.
Source: https://medicalxpress.com/news/2025-06-gilead-yearly-hiv.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into How the Brain Modulates Sensory Perception in Real-Time
New research uncovers a novel brain mechanism that modulates sensory perception by influencing neuron excitability in the somatosensory cortex, offering insights into perception variability and potential disorders.
The Impact of Internet Bots on Scientific Research Integrity
The rise of sophisticated internet bots and AI technologies presents significant challenges to maintaining integrity in online scientific research, risking data validity and trust.
Virtual Reality Nature Scenes Show Promise in Reducing Pain Sensitivity
Virtual reality immersion in natural scenes has been shown to reduce pain sensitivity, especially when users feel a strong sense of presence, offering promising new avenues for pain management.